MAP2K7 and atrial fibrillation: In cells treated with 100 μM of U126, a specific MEK inhibitor (Philipova et al., 2005a), cdk2 kinase activity was inhibited by 70% at 4 min and 95% at 70 min AF compared to controls (Figs. 2C, D).